For years, doctors have given cancer patients three main treatments: surgery, radiation and chemotherapy. Now researchers are developing a fourth weapon: the patient’s own immune system. New vaccines and drugs can stimulate the production of an army of cells and antibodies that kill cancer cells...
The article names three cancer treatments which the National Institute for Health & Clinical Excellence (NICE) in Great Britain has rejected as maintenance therapy for cancer treatments including the use of erlotinib or Tarceva for patients with non-small cell lung cancer, vinflunine or Javlor for ...
Elderly survivors of breast cancer, lung cancer, and melanoma face risk of brain metastasis later in life, and may require extra surveillance in the years following initial cancer treatment. "Ascancertreatments have gotten better and more people are surviving a primary cancer diagnosis, it's import...
Most pituitary adenomas (PAs) are noninvasive and grow slowly, first-line treatment typically managed with transsphenoidal surgery or medications like bromocriptine or cabergoline. However, 2.5% to 10% of PAs are aggressive, recurrent, and show resistance not only to these standard treatments but ...
the Translational Genomics Research Institute (TGen), part of City of Hope, a coast-to-coast clinical trial is planned that, if successful, could lead to FDA approval of the first new drug treatment in more than a decade for glioblastoma, the most common and aggressive type of brain cancer...
Expression of the major myelin gene Mpz was not affected by these treatments, while Pmp22 gene expression (when normalised to that of Mpz) was decreased by the presence of PXT3003 but not by its constitutive drugs. Interestingly, this specific effect on Pmp22 but not on Mpz expression is ...
For years, doctors have given cancer patients three main treatments: surgery, radiation and chemotherapy. Now researchers are developing a fourth weapon: the patient's own immune system. New vaccines and drugs can stimulate the production o..
Moreover, stemofoline (1) has been found to alleviate inflammation34 and reverse multidrug resistance of certain types of cancer15,35,36,37. Indeed, it has been shown that stemofoline (1) increases the sensitivity of patients toward anticancer drugs such as vinblastine, paclitaxel, and ...
Such cancer cells were found to be enriched in patient-derived 3D organoids surviving 5-fluorouracil treatment. Conclusions The single cell-based 3D organoid system may serve as a highly efficient platform to explore cancer therapeutics and therapy resistance mechanisms in conjunction with morphological ...
The PINC trial (Preventing Invasive Neoplasia withChloroquine) targetsductal carcinomain situ, or DCIS, the most common type of pre-invasive breast cancer. Chloroquine is a drug given to prevent or treat malaria; it's showing promise in the early phase of the PINC trial. ...